期刊文献+

痴呆在中国70年发展历程 被引量:2

Seventy Years of Dementia Management in China
下载PDF
导出
摘要 痴呆是个古老又新鲜的医学概念和健康问题。说古老是因为两千年前就已出现的医学名词,说新鲜是说现代医学认识的痴呆的主要代表疾病——阿尔茨海默病才一百余年。今年是中华人民共和国成立70周年。回顾70年新中国卫生健康事业发展波澜壮阔的历程,取得的成就举世瞩目。经过广大医疗卫生、科研工作者等的共同努力,中国的痴呆相关临床科学和基础研究也取得了长足的发展。未来将面临人口老龄化这一重大挑战,痴呆已经成为优先解决的重大健康问题和社会问题,社会的方方面面都应该进行重新调整,以应对这样的挑战。 Dementia is an old and fresh medical concept and health problem. Although as a medical term it appeared two thousand years ago,Alzheimer’s disease as the main representation of dementia,it has only been known for 100 years or so. This year is the 70 th anniversary of the People’ s Republic of China’ s establishment. Looking back on the magnificent development of the healthcare industry in New China in the past 70 years,the achievements have attracted worldwide attention. In the joint efforts of the vast number of healthcare practitioners,and scientific research workers,the clinical and basic research of dementia have made great progress in China. The aging of the population is a great challenge in the future,and dementia has become a major health and social priority,that all aspects of society should be realigned to meet such challenges.
作者 纪勇 JI Yong(China National Clinical Research Center for Neurological Diseases,Beijing 100070,China;Department of Neurology,Tianjin Huanhu Hospital,Tianjin 300350,China)
出处 《医学综述》 2019年第18期3537-3540,共4页 Medical Recapitulate
关键词 痴呆 阿尔茨海默病 简易智力状态检查量表 Dementia Alzheimer’s disease Mini-mental State Examination
  • 相关文献

参考文献2

二级参考文献16

  • 1CaiLS, lnnis RB, Pike VW. Radioligand development for PET imaging of β-amyloid (Aβ)-current status. Curr Med Chem 2007; 14: 19-52.
  • 2Klunk WE, Lopresti B J, Ikonomovic MD, Lefterov IM, Koldamova RP. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 2005; 25:10 598-606.
  • 3Toyama H, Ye D, Ichise M, Liow JS, Cai LS, Jacobowitz D, et al. PET imaging of brain with the [β-amyloid probe, [^11C]6-OHBTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imag 2005; 32: 593-600.
  • 4Cai LS, Ye D, Liow JS, Hong J, Cohen RM, Pike VW, et al. PET imaging of transgenic mice TG2576 using the beta-amyloid radioligand, [C-11]PIB. Neuroimage 2006; 31: T44-TI86.
  • 5Shimadzu H, Suemoto T, Suzuki M, Shiomitsu T, Okamura N, Kudo Y, et al. Novel probes for imaging amyloid-β: F-18 and C-11 labeling of 2-(4-aminostyryl)benzoxazole derivatives. J La- bel Compd Radiopharm 2004; 47: 181-90.
  • 6Zheng MQ, Yin DZ, Shen YM, Li GC. Syntheses of 2-(paminophenyl)-6-substituent-benzothiazoles. Chin J Organ Chem 2007; 27: 1369-73. Chinese.
  • 7Mathis CA, Holt DE Wang Y, Huang GF, Debnath ML, Klunk WE. F-18-labeled thioflavin-T analogs for amyloid assessment. J Nucl Med 2002; 43: p166.
  • 8Zheng MQ, Yin DZ, Zhang L, Cheng DF, Wang YX, Cai HC. Synthesis and evaluation of ^18F-labelled PIB as amyloid imaging agents. J Label Compd Radiopharm 2007; 50 (Suppl 1): S401.
  • 9Cheng DF, Yin DZ, Li GC, Wang MW, Li SQ, Zheng MQ, et al.Radiolabeling and in vitro and in vivo characterization of [^18F]FB- [R8,15,21, L17]-VIP as a PET imaging agent for tumor overexpressed VIP receptors. Chem Biol Drug Design 2006; 68: 319-25.
  • 10Zheng MQ, Yin DZ, Qiao JE Zhang L, Wang YX. Syntheses and evaluation of fluorinated benzothiazole anilines as potential tracers for β-amyloid plaques in Alzheimer's disease. J Fluorine Chem 2008; 129: 210-6.

共引文献68

同被引文献31

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部